Mechanism and positioning (context) Nimotuzumab is a humanized monoclonal antibody targeting EGFR. It has been developed and used in multiple countries for EGFR driven epithelial tumors and certain gliomas, typically as an add on to radiotherapy and or chemotherapy rather than as a standalone replacement for standard regimens. ScienceDirect 1) Effectiveness of Nimotuzuma 1.1 Head...

